S8 Ep9: Rugo Summarizes Developments With Ribociclib and ADCs in HR-Positive Breast Cancer
OncLive® On Air
00:00
Intro
This chapter explores the pivotal results from the TROPICS-02 trial on the efficacy of sasetuzumab govitecan for hormone receptor-positive breast cancer. It highlights significant improvements in patient outcomes and the implications of TROPE-2 expression levels on treatment effectiveness.
Play episode from 00:00
Transcript
